149 related articles for article (PubMed ID: 22917691)
1. Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
Sbardella E; Greco A; Stromillo ML; Prosperini L; Puopolo M; Cefaro LA; Pantano P; De Stefano N; Minghetti L; Pozzilli C
Mult Scler; 2013 Apr; 19(4):411-7. PubMed ID: 22917691
[TBL] [Abstract][Full Text] [Related]
2. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome.
Orbach R; Gurevich M; Achiron A
Mult Scler; 2014 Jan; 20(1):35-42. PubMed ID: 23722323
[TBL] [Abstract][Full Text] [Related]
4. Assessing tissue damage in multiple sclerosis: a biomarker approach.
Burman J; Zetterberg H; Fransson M; Loskog AS; Raininko R; Fagius J
Acta Neurol Scand; 2014 Aug; 130(2):81-9. PubMed ID: 24571714
[TBL] [Abstract][Full Text] [Related]
5. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
[TBL] [Abstract][Full Text] [Related]
6. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
7. N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry.
Jasperse B; Jakobs C; Eikelenboom MJ; Dijkstra CD; Uitdehaag BM; Barkhof F; Polman CH; Teunissen CE
J Neurol; 2007 May; 254(5):631-7. PubMed ID: 17415509
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
Gajofatto A; Bongianni M; Zanusso G; Bianchi MR; Turatti M; Benedetti MD; Monaco S
Acta Neurol Scand; 2013 Nov; 128(5):336-44. PubMed ID: 23550839
[TBL] [Abstract][Full Text] [Related]
9. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.
Durante L; Zaaraoui W; Rico A; Crespy L; Wybrecht D; Faivre A; Reuter F; Malikova I; Pommier G; Confort-Gouny S; Cozzone PJ; Ranjeva JP; Pelletier J; Boucraut J; Audoin B
Mult Scler; 2012 May; 18(5):587-91. PubMed ID: 21965422
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
Teunissen CE; Sombekke M; van Winsen L; Killestein J; Barkhof F; Polman CH; Dijkstra CD; Blankenstein MA; Pratico D
Mult Scler; 2012 Aug; 18(8):1092-8. PubMed ID: 22695538
[TBL] [Abstract][Full Text] [Related]
12. [Acute posterior cord lesions in multiple sclerosis. An MRI study of the clinical course in 20 cases].
Pou Serradell A; Roquer González J; Perich Alsina X
Rev Neurol (Paris); 2000 Dec; 156(12):1126-35. PubMed ID: 11139729
[TBL] [Abstract][Full Text] [Related]
13. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
[TBL] [Abstract][Full Text] [Related]
14. Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Kuhle J; Malmeström C; Axelsson M; Plattner K; Yaldizli O; Derfuss T; Giovannoni G; Kappos L; Lycke J
Acta Neurol Scand; 2013 Dec; 128(6):e33-6. PubMed ID: 23763388
[TBL] [Abstract][Full Text] [Related]
15. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
[TBL] [Abstract][Full Text] [Related]
16. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
Brettschneider J; Petzold A; Junker A; Tumani H
Mult Scler; 2006 Apr; 12(2):143-8. PubMed ID: 16629417
[TBL] [Abstract][Full Text] [Related]
17. Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.
Sbardella E; Tomassini V; Stromillo ML; Filippini N; Battaglini M; Ruggieri S; Ausili Cefaro L; Raz E; Gasperini C; Sormani MP; Pantano P; Pozzilli C; De Stefano N
Mult Scler; 2011 Dec; 17(12):1432-40. PubMed ID: 21729978
[TBL] [Abstract][Full Text] [Related]
18. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
Valis M; Talab R; Stourac P; Andrys C; Masopust J
Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosis.
Greco A; Minghetti L; Puopolo M; Cannoni S; Romano S; Pozzilli C; Levi G
J Neurol Sci; 2004 Sep; 224(1-2):23-7. PubMed ID: 15450767
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of acute partial transverse myelitis.
Bourre B; Zéphir H; Ongagna JC; Cordonnier C; Collongues N; Debette S; Fleury MC; Outteryck O; Hannequin D; Vermersch P; de Seze J
Arch Neurol; 2012 Mar; 69(3):357-62. PubMed ID: 22410443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]